These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 25738956)

  • 41. Development of acquired drug resistance in recurrent tuberculosis patients with various previous treatment outcomes.
    Yoshiyama T; Yanai H; Rhiengtong D; Palittapongarnpim P; Nampaisan O; Supawitkul S; Uthaivorawit W; Mori T
    Int J Tuberc Lung Dis; 2004 Jan; 8(1):31-8. PubMed ID: 14974743
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Later emergence of acquired drug resistance and its effect on treatment outcome in patients treated with Standard Short-Course Chemotherapy for tuberculosis.
    Gao J; Ma Y; Du J; Zhu G; Tan S; Fu Y; Ma L; Zhang L; Liu F; Hu D; Zhang Y; Li X; Li L; Li Q
    BMC Pulm Med; 2016 Feb; 16():26. PubMed ID: 26846562
    [TBL] [Abstract][Full Text] [Related]  

  • 43. First- and second-line anti-tuberculosis drug resistance in Northwest Ethiopia.
    Tessema B; Beer J; Emmrich F; Sack U; Rodloff AC
    Int J Tuberc Lung Dis; 2012 Jun; 16(6):805-11. PubMed ID: 22390880
    [TBL] [Abstract][Full Text] [Related]  

  • 44. First national survey of Mycobacterium tuberculosis drug resistance, Madagascar, 2005-2006.
    Ramarokoto H; Ratsirahonana O; Soares JL; Ravaosolo J; Ravololonandriana P; Rakotoarisaonina A; Ranjalahy G; Ranaivohajaina S; Mosa M; Robinson R; Ratsitorahina M; Rasolofo V; Rarivoson B
    Int J Tuberc Lung Dis; 2010 Jun; 14(6):745-50. PubMed ID: 20487614
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Anti-tuberculosis drug resistance in Bangladesh: reflections from the first nationwide survey.
    Kamal SM; Hossain A; Sultana S; Begum V; Haque N; Ahmed J; Rahman TM; Hyder KA; Hossain S; Rahman M; Ahsan CR; Aung KJ; Islam A; Hasan R; Van Deun A
    Int J Tuberc Lung Dis; 2015 Feb; 19(2):151-6. PubMed ID: 25574912
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Evaluation of the direct nitrate reductase assay for rapid detection of extensively drug-resistant tuberculosis.
    Huang ZK; Luo Q; Qing C; Deng YT; Xiong GL; Li JM
    Int J Tuberc Lung Dis; 2016 Apr; 20(4):468-73. PubMed ID: 26970155
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prevalence and molecular characteristics of drug-resistant Mycobacterium tuberculosis in Beijing, China: 2006 versus 2012.
    Yin QQ; Jiao WW; Li QJ; Xu F; Li JQ; Sun L; Li YJ; Huang HR; Shen AD
    BMC Microbiol; 2016 May; 16():85. PubMed ID: 27176471
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Tuberculosis in Australia: bacteriologically confirmed cases and drug resistance, 2008 and 2009. A report of the Australian Mycobacterium Reference Laboratory Network.
    Lumb R; Bastion I; Carter R; Jelfs P; Keehner T; Sievers A
    Commun Dis Intell Q Rep; 2011 Jun; 35(2):154-61. PubMed ID: 22010508
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Distribution patterns of drug resistance Mycobacterium tuberculosis among HIV negative and positive tuberculosis patients in Western Kenya.
    Ogwang MO; Imbuga M; Ngugi C; Mutharia L; Magoma G; Diero L
    BMC Infect Dis; 2021 Nov; 21(1):1175. PubMed ID: 34809602
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Has introduction of rapid drug susceptibility testing at diagnosis impacted treatment outcomes among previously treated tuberculosis patients in Gujarat, India?
    Dave P; Vadera B; Kumar AM; Chinnakali P; Modi B; Solanki R; Patel P; Patel P; Pujara K; Nimavat P; Shah A; Bharaswadkar S; Rade K; Parmar M; Nair SA
    PLoS One; 2015; 10(4):e0121996. PubMed ID: 25874545
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Drug resistance rates of Mycobacterium tuberculosis at a private referral center in Korea.
    Choi JC; Lim SY; Suh GY; Chung MP; Kim H; Kwon OJ; Lee NY; Park YK; Bai GH; Koh WJ
    J Korean Med Sci; 2007 Aug; 22(4):677-81. PubMed ID: 17728509
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Drug resistance among smear-positive tuberculosis patients in Ho Chi Minh City, Vietnam.
    Quy HT; Buu TN; Cobelens FG; Lan NT; Lambregts CS; Borgdorff MW
    Int J Tuberc Lung Dis; 2006 Feb; 10(2):160-6. PubMed ID: 16499254
    [TBL] [Abstract][Full Text] [Related]  

  • 53. An epidemiological study of tuberculosis and HIV infection in Tanzania, 1991-1993.
    Chum HJ; O'Brien RJ; Chonde TM; Graf P; Rieder HL
    AIDS; 1996 Mar; 10(3):299-309. PubMed ID: 8882670
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Multidrug-resistant tuberculosis in Bangladesh: results from a sentinel surveillance system.
    Banu S; Rahman MT; Ahmed S; Khatun R; Ferdous SS; Hosen B; Rahman MM; Ahmed T; Cavanaugh JS; Heffelfinger JD
    Int J Tuberc Lung Dis; 2017 Jan; 21(1):12-17. PubMed ID: 28157459
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Anti-tuberculosis drug resistance pattern among pulmonary tuberculosis patients with or without HIV infection in Mwanza, Tanzania.
    Range N; Friis H; Mfaume S; Magnussen P; Chanualucha J; Kilale A; Mugomela A; Andersen AB
    Tanzan J Health Res; 2012 Oct; 14(4):243-9. PubMed ID: 26591721
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Outcomes of patients with multidrug-resistant pulmonary tuberculosis treated with ofloxacin/levofloxacin-containing regimens.
    Yew WW; Chan CK; Chau CH; Tam CM; Leung CC; Wong PC; Lee J
    Chest; 2000 Mar; 117(3):744-51. PubMed ID: 10713001
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Evaluation of the microscopic observation drug susceptibility assay for the rapid detection of MDR-TB and XDR-TB in China: a prospective multicentre study.
    Huang Z; Qin C; Du J; Luo Q; Wang Y; Zhang W; Zhang X; Xiong G; Chen J; Xu X; Li W; Li J
    J Antimicrob Chemother; 2015 Feb; 70(2):456-62. PubMed ID: 25266071
    [TBL] [Abstract][Full Text] [Related]  

  • 58. HIV coinfection among multidrug resistant and extensively drug resistant tuberculosis patients--a trend.
    Rajasekaran S; Chandrasekar C; Mahilmaran A; Kanakaraj K; Karthikeyan DS; Suriakumar J
    J Indian Med Assoc; 2009 May; 107(5):281-2, 284-6. PubMed ID: 19886382
    [TBL] [Abstract][Full Text] [Related]  

  • 59. API TB Consensus Guidelines 2006: Management of pulmonary tuberculosis, extra-pulmonary tuberculosis and tuberculosis in special situations.
    API Consensus Expert Committee
    J Assoc Physicians India; 2006 Mar; 54():219-34. PubMed ID: 16800350
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Screening outcomes from patients with suspected multidrug-resistant tuberculosis: lessons learned in the Philippines.
    Gler MT; Guilatco RS; Guray CV; Tupasi TE
    Int J Tuberc Lung Dis; 2012 Oct; 16(10):1326-30. PubMed ID: 22863522
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.